Company / PP&E per Share
BIOCRYST PHARMACEUTICALS INC PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.04
FY2025
5-year range
$0.04 / $0.05
FY2021-FY2025
Trend
+6.8%
vs FY2024
Sector context
#126 of 191
Health Care
What the data says
At $0.04, BIOCRYST PHARMACEUTICALS INC's pp&e per share ranks #126 of 191 in the Health Care sector. PP&E per Share returned to growth in FY2025 after 3 years of decline, reaching $0.04.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of -1.1%.
Declined from $0.04 to $0.04 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -4.6%
- 5-Year CAGR
- -1.1%
- 10-Year CAGR
- -
Sector benchmark
#126 of 191 in Health CareTop 66% of 191This company $0.04 Sector average $18.90
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 6.8% year-over-year.
- Ranks #126 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2016.
- Lowest pp&e per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | +6.8% |
| FY2024 | $0.04 | -8.6% |
| FY2023 | $0.04 | -11.2% |
| FY2022 | $0.05 | -4.7% |
| FY2021 | $0.05 | +14.4% |
| FY2020 | $0.04 | -33.1% |
| FY2019 | $0.06 | -28.2% |
| FY2018 | $0.09 | -31.6% |
| FY2017 | $0.13 | -4.3% |
| FY2016 | $0.14 | +89.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026